Primary experimental recordPositive observation

PMC12830260::ACT034414

TXM-CB3

Evidence text

Paper-level observation

Fig. 1B: CB3 (50 μM or 100 μM, 2 h) significantly attenuated this fluorescence response in a concentration-dependent manner, reducing signal to ~250% and ~180% of baseline, respectively.

textConfidence: medium

Assay observation

Activity

Antioxidant

Subtype

Antibacterial

Measure

percent_inhibition

Comparator

Raw observation

reduced HEt fluorescence to ~250% (50 μM) and ~180% (100 μM) of baseline vs ~336% in low Mg2+ alone % of baseline

Normalized measurement

~250 other

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

Rattus norvegicus

Assay method

Not reported by source

Sequence

ACCPCNH

Standardization

ready simple

Assay conditions

"original_unit=% of baseline"

Source publication

Thioredoxin-mimetic peptide attenuates epilepsy progression and neurocognitive deficits

Redox Biology · 2026

DOI 10.1016/j.redox.2026.104021 PMC12830260

Parent mention

Related peptide identities

PEPDIA-PLP-000024

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.